Pharmaceutical Products Companies By Held By Institutions
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Shares Owned By Institutions
| Shares Owned By Institutions | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | DVAX | Dynavax Technologies | 0.10 | 1.20 | 0.11 | ||
| 2 | MRVI | Maravai Lifesciences Holdings | (0.01) | 4.85 | (0.04) | ||
| 3 | VCEL | Vericel Corp Ord | 0.03 | 1.89 | 0.05 | ||
| 4 | MRUS | Merus BV | (0.04) | 2.55 | (0.10) | ||
| 5 | MLYS | Mineralys Therapeutics, Common | (0.07) | 4.28 | (0.28) | ||
| 6 | MIRM | Mirum Pharmaceuticals | 0.14 | 2.18 | 0.31 | ||
| 7 | OKUR | OnKure Therapeutics, | (0.34) | 4.73 | (1.59) | ||
| 8 | VERV | Verve Therapeutics | 0.17 | 6.94 | 1.17 | ||
| 9 | MGNX | MacroGenics | (0.14) | 3.25 | (0.45) | ||
| 10 | VERA | Vera Therapeutics | (0.21) | 3.64 | (0.77) | ||
| 11 | MRSN | Mersana Therapeutics | (0.19) | 9.14 | (1.69) | ||
| 12 | DNLI | Denali Therapeutics | (0.04) | 3.83 | (0.14) | ||
| 13 | MDGL | Madrigal Pharmaceuticals | 0.05 | 3.32 | 0.17 | ||
| 14 | DNTH | Dianthus Therapeutics | 0.06 | 4.48 | 0.25 | ||
| 15 | UPB | Upstream Bio, | (0.23) | 6.71 | (1.55) | ||
| 16 | MLTX | MoonLake Immunotherapeutics | (0.05) | 3.19 | (0.17) | ||
| 17 | MRNS | Marinus Pharmaceuticals | 0.17 | 7.37 | 1.22 | ||
| 18 | VIGL | Vigil Neuroscience | 0.00 | 5.89 | 0.02 | ||
| 19 | VKTX | Viking Therapeutics | (0.19) | 3.98 | (0.77) | ||
| 20 | MRNA | Moderna | (0.02) | 4.88 | (0.08) |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen. Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.